Cargando…

Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy

BACKGROUND: The excessive amounts of immunosuppressive factors present in a tumor microenvironment (TME) reduce the effectiveness of cancer vaccines. The main objective of our research was to improve the effectiveness of dendritic cell (DC)-based immunotherapy or chemoimmunotherapy composed of cyclo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossowska, Joanna, Anger, Natalia, Szczygieł, Agnieszka, Mierzejewska, Jagoda, Pajtasz-Piasecka, Elżbieta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6025815/ https://www.ncbi.nlm.nih.gov/pubmed/29954431 http://dx.doi.org/10.1186/s13046-018-0799-y

Ejemplares similares

Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells
por: Rossowska, Joanna, et al.
Publicado: (2017)

Treatment with lentiviral vectors encoding shRNA against interleukin 10 modulates the immunosuppressive activity of murine colon carcinoma-associated myeloid-derived suppressor cells
por: Anger-Góra, Natalia, et al.
Publicado: (2021)

Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1
por: Rossowska, Joanna, et al.
Publicado: (2019)

Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
por: Węgierek-Ciura, Katarzyna, et al.
Publicado: (2023)

The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022)

Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell-based vaccines in murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2021)

Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2023)

Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4(+) T cell response against MC38 colon carcinoma
por: WOJAS-TUREK, JUSTYNA, et al.
Publicado: (2015)

Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models
por: Kicielińska, Jagoda, et al.
Publicado: (2016)

DC-targeting lentivectors for cancer immunotherapy
por: Gea-Mallorquí, Ester, et al.
Publicado: (2023)

Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
por: Wróblewska, Anna, et al.
Publicado: (2023)

Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
por: Terasawa, Kazuya, et al.
Publicado: (2011)

Immunogenicity of targeted lentivectors
por: Goyvaerts, Cleo, et al.
Publicado: (2014)

Synthesis and Characterization of Boron Carbide Nanoparticles as Potential Boron-Rich Therapeutic Carriers
por: Kozień, Dawid, et al.
Publicado: (2023)

A Random shRNA-Encoding Library for Phenotypic Selection and Hit-Optimization
por: Wang, Yongping, et al.
Publicado: (2008)

Structural and immunomodulatory differences among lactobacilli exopolysaccharides isolated from intestines of mice with experimentally induced inflammatory bowel disease
por: Górska, Sabina, et al.
Publicado: (2016)

A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2
por: Borkent, Marti, et al.
Publicado: (2016)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

The role of immune cell subpopulations in the growth and rejection of TC-1/A9 tumors in novel mouse strains differing in the H2-D haplotype and NKC domain
por: Indrová, Marie, et al.
Publicado: (2018)

Introduction of Mismatches in a Random shRNA-Encoding Library Improves Potency for Phenotypic Selection
por: Wang, Yongping, et al.
Publicado: (2014)

Dendritic Cell-Directed Vaccination with a Lentivector Encoding PSCA for Prostate Cancer in Mice
por: Xiao, Liang, et al.
Publicado: (2012)

Boron-Rich Boron Carbide Nanoparticles as a Carrier in Boron Neutron Capture Therapy: Their Influence on Tumor and Immune Phagocytic Cells
por: Kozień, Dawid, et al.
Publicado: (2021)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5
por: Shimizu, Saki, et al.
Publicado: (2009)

Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy
por: Yu, Xinyang, et al.
Publicado: (2023)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Production of Transgenic Calves Expressing an shRNA Targeting Myostatin
por: Tessanne, K, et al.
Publicado: (2012)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Stable expression of shRNA for the control of recombinant adenovirus replication
por: Lana, M.V.G., et al.
Publicado: (2023)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

Coupling shRNA screens with single-cell RNA-seq identifies a dual role for mTOR in reprogramming-induced senescence
por: Aarts, Marieke, et al.
Publicado: (2017)

Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells
por: Zhao, N, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_q0iii9um1tv7gsa3drgjasvbfu